cIQc Non-Small Cell Lung Cancer EQA for PD-L1
Emina Emilia Torlakovic, MD, PhD, FCAP
Adjunct Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto.
Staff Hematopathologist, William Osler Health System, Toronto, Ontario.
Dr. Torlakovic received her MD at the University of Zagreb, completed her residency in Anatomical and Clinical Pathology and fellowships in Hematopathology and Surgical Pathology at the University of Minnesota, MN, USA. She is a Diplomate of the American Board of Pathology in Anatomical and Clinical Pathology and Hematopathology. She has authored over 100 peer-reviewed manuscripts and also published author of book/book chapters. She led several national and international published guidelines in the field of immunohistochemistry and is also a co-author of ASCO/CAP guidelines for ER/PR testing in breast cancer. Dr. Torlakovic is a founding member of NordiQC, Canadian Immunohistochemistry Quality Control (cIQc), as well as International Society for Immunohistochemistry and Molecular Morphology (ISIMM). She is the Chair of the Canadian Association of Pathologists’ National Standards Committee for High Complexity Laboratory Testing and also co-directs cIQc. She has widely lectured in the field of quality assurance as well as in hematopathology. She is also internationally recognized for her seminal work in and discovery of sessile serrated adenoma.